Klebsiella pneumoniae, a bacterium found in the gut, may reach the brain and affect Alzheimer's disease progression, research ...

Roche later made changes to the trial design, although the company said overall results support further testing.

Braisted said wandering is a risk for every person living with Alzheimer's or other dementias. "So, it's really important to ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

An Alzheimer’s drug from Roche cleared a protein that’s a hallmark of the disease from patients’ brains, suggesting the drug ...

U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...

The overall rate of emergency room visits for older adults with Alzheimer's disease was 36.1 visits per 1,000 adults in ...

Coya Therapeutics said on Tuesday its experimental Alzheimer's drug was safe and increased levels of a type of immune cells ...

Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...

Alzheimer's disease, the leading cause of dementia, affects over 55 million people worldwide. The disease is characterized by ...

Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...

The medical community remains committed to improving treatment for those living with Alzheimer’s and other forms of dementia.